ChemicalBook >?? ???? >(S)-4,4'-(1-??-1,2-????)??-2,6-?????????
(S)-4,4'-(1-??-1,2-????)??-2,6-?????????
|
|
(S)-4,4'-(1-??-1,2-????)??-2,6-????????? ??
- ?? ??
- Inert atmosphere,Room Temperature
- ???
- ≥ 15.24mg/mL in DMSO
- ??? ??
- Solid
- ??
- White to off-white
??
- ?? ? ?? ??
- ?? ? ???? ?? (GHS)
????(GHS): | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
?? ?: | Warning | |||||||||||||||||||||
??·?? ??: |
|
|||||||||||||||||||||
??????: |
|
(S)-4,4'-(1-??-1,2-????)??-2,6-????????? C??? ??, ??, ??
Mechanism of action
As a derivative of EDTA, dexrazoxane chelates iron and thus reduces the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals. The exact chelation mechanism is unknown, but it has been postulated that dexrazoxane can be converted into ring-opened form intracellularly and interfere with iron-mediated free radical generation that is in part thought to be responsible for anthryacycline induced cardiomyopathy. It was speculated that dexrazoxane could be used for further investigation to synthesize new antimalarial drugs.??
Dexrazoxane is used to reduce the risk and severity of heart damage caused by doxorubicin treatment and similar cancer chemotherapy medications. Heart damage limits the length of time you can be treated with doxorubicin. Dexrazoxane allows you to continue doxorubicin treatment for longer. When used for this purpose, dexrazoxane treatment is usually started after you have received several doses of doxorubicin. It is usually not given with the first doses of doxorubicin since doing so may reduce the effectiveness of doxorubicin.(S)-4,4'-(1-??-1,2-????)??-2,6-????????? ?? ?? ? ???
???
?? ??
(S)-4,4'-(1-??-1,2-????)??-2,6-????????? ?? ??
???( 116)?? ??
??? | ?? | ??? | ?? | ?? ? | ?? |
---|---|---|---|---|---|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | +86-18600796368 +86-18600796368 |
sales@sjar-tech.com | China | 375 | 58 |
Beijing Cooperate Pharmaceutical Co.,Ltd | 010-60279497 |
sales01@cooperate-pharm.com | CHINA | 1803 | 55 |
Hangzhou FandaChem Co.,Ltd. | 008657128800458; +8615858145714 |
fandachem@gmail.com | China | 9218 | 55 |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32820 | 60 |
Biocare Pharmaceutical Ltd | +86-23-63023096 |
contact@boeingpharm.com | CHINA | 2 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49374 | 58 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
factory@coreychem.com | China | 29815 | 58 |
Shaanxi Dideu Medichem Co. Ltd | +86-29-87569266 15319487004 |
1015@dideu.com | China | 4088 | 58 |
Zhengzhou Alfa Chemical Co.,Ltd | +8618530059196 |
sale04@alfachem.cn | China | 13486 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32002 | 58 |